Table 5 Prevalence of AHI-PI High Risk Indications in the hours prior to the onset of the first EHI across all patients (NIBP and IAP monitored)
Statistic | Monitoring Modality | 0–1 h | 1–2 h | 2–3 h | 3–4 h | 4–5 h |
|---|---|---|---|---|---|---|
N patients | NIBP | 380 | 315 | 264 | 234 | 216 |
IAP | 312 | 255 | 220 | 193 | 171 | |
Median [25th, 75th] | NIBP | 100% [46.7%, 100%] | 89.7% [0%, 100%] | 69.1% [0%, 100%] | 48.8% [0%, 100%] | 45.4% [0%, 100%] |
IAP | 100% [43.3%, 100%] | 90.0% [0%, 100%] | 61.7% [0%, 100%] | 26.7% [0%, 100%] | 0% [0%, 100%] | |
Mean [Std Dev] | NIBP | 74.2% [38.9%] | 58.8% [45.1%] | 54.3% [45.8%] | 48.8% [46.2%] | 45.4% [45.7%] |
IAP | 72.3% [39.2%] | 58.5% [45.2%] | 53.1% [46.1%] | 45.9% [46.5%] | 40.1% [46.1%] |